|
ZNF143 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.799020E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.458600E-03 |
| Normal-vs-Stage2 |
1.78606999999831E-05 |
| Normal-vs-Stage3 |
2.758100E-04 |
| Normal-vs-Stage4 |
7.64209999948307E-07 |
| Stage1-vs-Stage2 |
2.125800E-02 |
| Stage1-vs-Stage3 |
2.581000E-01 |
| Stage1-vs-Stage4 |
5.804800E-03 |
| Stage2-vs-Stage3 |
1.985230E-01 |
| Stage2-vs-Stage4 |
8.628600E-01 |
| Stage3-vs-Stage4 |
1.668810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.378700E-04 |
| Normal-vs-AfricanAmerican |
8.951700E-02 |
| Normal-vs-Asian |
1.002600E-01 |
| Caucasian-vs-AfricanAmerican |
4.281000E-01 |
| Caucasian-vs-Asian |
1.607400E-01 |
| AfricanAmerican-vs-Asian |
8.267200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.88259999980944E-07 |
| Normal-vs-Female |
3.804700E-04 |
| Male-vs-Female |
6.523600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.035910E-02 |
| Normal-vs-Age(41-60Yrs) |
5.58319999999224E-05 |
| Normal-vs-Age(61-80Yrs) |
1.82319999997294E-06 |
| Normal-vs-Age(81-100Yrs) |
2.029800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.457700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.719000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.783000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.960580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.580400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.554600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.494450E-01 |
| Classical-VS-Follicular |
2.06409999999879E-05 |
| Classical-VS-Other |
4.395200E-01 |
| Classical-VS-Normal |
1.135730E-02 |
| Tall-VS-Follicular |
1.423210E-01 |
| Tall-VS-Other |
9.778400E-01 |
| Tall-VS-Normal |
3.777400E-03 |
| Follicular-VS-Other |
4.486600E-01 |
| Follicular-VS-Normal |
1.67159999953093E-07 |
| Other-VS-Normal |
8.621800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.81069999952655E-07 |
| Normal-vs-N1 |
1.256740E-03 |
| N0-vs-N1 |
4.162200E-01 |
|
|
